Waters Corporation (WAZ.F)
| Previous Close | 306.50 |
| Open | 300.90 |
| Bid | 300.80 x 40000 |
| Ask | 308.00 x 40000 |
| Day's Range | 300.90 - 300.90 |
| 52 Week Range | 222.00 - 329.40 |
| Volume | |
| Avg. Volume | 1 |
| Market Cap | 17.849B |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | 32.08 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference
Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2024 Healthcare Conference on Wednesday, June 5th, 2024 at 9:30AM Eastern Time.
- PR Newswire
ObeEnd - Pioneering Drug-Free Weight Management Wristband
WAT Medical, a leader in innovative healthcare solutions, announces the development of ObeEnd, the world's first weight management wristband backed by clinical evidence showcasing its efficacy in reducing dietary intake. Findings from this groundbreaking study were presented at the Canadian Nutrition Society annual conference in May 2024.
- PR Newswire
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument
Waters Corporation (NYSE:WAT) today announced the release of the ACQUITY QDa II Mass Detector, the evolution of its highly successful, compact, and streamlined mass detection instrument that delivers high-quality, mass spectral data to chromatographic separations. This new and improved mass detector allows scientists to analyze a wider range of chemical entities with a robust, cost-effective, low energy consumption solution. It enhances and complements Waters best-in-class ACQUITY Premier Liquid
